Počet záznamov: 1
The combination of PRL-3 inhibitor with sorafenib synergistically promotes AML apoptosis
SYS 0176131 LBL 00000naa--2200000-a-4500 005 20250607173804.2 008 211021s2021----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng $b eng 044 $a xo $c SK 245 14
$a The combination of PRL-3 inhibitor with sorafenib synergistically promotes AML apoptosis / $c Xiaomin Chen ... [et al.] 300 $b ilustr., grafy, obr., tab. 504 $a Bibliogr. odkazy 504 $a Res. angl. 650 12
$7 sllk_us_auth*d015470 $a leukémia myeloidná akútna $2 mesh 650 22
$7 sllk_us_auth*d017027 $a proteín tyrozín fosfatázy $2 mesh 650 22
$7 sllk_us_auth*d000077157 $a sorafenib $2 mesh 650 12
$7 sllk_us_auth*d045744 $a línia bunková nádorová $2 mesh 650 22
$7 sllk_us_auth*d008819 $a myši nahé $2 mesh 653 2-
$a inhibítor PRL-3 (phosphatase of regenerating liver-3) 653 2-
$a BR-1 653 2-
$a štúdia experimentálna 700 1-
$7 sllk_us_auth*0054607 $a Chen, Xiaomin $4 aut 773 0-
$7 nnas $w sllk_us_cat*0175762 $t Neoplasma $f Cancer Research Institute of the Slovak Academy of Sciences $x 0028-2685 $d Bratislava : AEPress, 2021 $g Vol. 68, no. 4 (2021), s. 832-841
Počet záznamov: 1